CLS Technology`s overriding business idea is to identify and develop products that contain Beta 1,3/1,6 D-glucan, Marine Phospolipids, Caviar Powder, and Vitamin K2-MK7, for the use in nutraceuticals, pharmaceuticals and cosmetic products. We will exploit, develop and protect collected knowledge within the areas of marine biology, pharmacology, medicine, and nutrition biology and process technology.
CLS Technology has a unique scientific competence in a crossover field relating to marine resources and to pharmacy. This specific expertise is an important asset in early identification of underexploited natural resources. The company’s focus will be on the development of new products, process optimization and development of applications in the core area of the company.
CLS Technology`s R&D focus is on documentation of the efficacy and bio availability of our active ingredients, and also to prove the health effect.